se of shitivara seed powder to access its efficacy on recurrent urinary tract infections

Not Applicable

• Conditions: Health Condition 1: N398- Other specified disorders of urinary system

• Registration Number: CTRI/2022/08/044690
• Lead Sponsor: Institute of medical sciences banars hindu university varanasi uttar pradesh

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1 Adult male and female subjects aged 18 to 60 years presenting symptoms of recurrent urinary tract infection with positive urine culture

2 Subjects willing to sign informed consent and follow the study procedure

3 Subjects who has not participated in any similar kind of clinical study in the last one month

4 Patients sensitive to the controlled drug

Exclusion Criteria

1 Complicated UTIs

2 known renal tract anomaly

3 Neurogenic bladder

4 Perform self-catheterization or has an indwelling catheter

5 Patients with incomplete bladder emptying

6 History of interstitial cystitis or painful bladder syndrome

7 Urothelial cancer

8 Pregnancy

9 Genital Herpes

10 Tuberculosis affecting the bladder

11 Diabetes mellitus

12 HIV and HBsAg positive subjects

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
According to Urinary Tract Infection Symptoms Assessment QuestionnaireTimepoint: Day0 4weeks 8weeks

Secondary Outcome Measures

Name	Time	Method
To observe the changes in quality of life in the patientsTimepoint: 60 days